LENNON DAVID JAMES (CHIEF EXECUTIVE OFFICER) received a stock award from WHITEHAWK THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/18/2026ACC: 0001995275-26-000014
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Mar 2026
+51.02K
Net shares
Net buyer
$200.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
51.02K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+51.02K
Price / share
$3.92
Trade value
$200K
% of position
9.8%
5/14/2026
518.62K→569.64K
Total
Net shares
+51.02K
Net value
$200K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/14/2026 | A · Award | +51.02K | $3.92 | $200K | 9.8% | 518.62K | 569.64K |
| Total | +51.02K | $200K | ||||||
Derivative Transactions0
No derivative transactions reported